InsiderDB

Lobbying disclosures · Lobbying report

WST: third_quarter 2026 lobbying report

Matters relating to the pharmaceutical manufacturing and supply chain security. Matters relating to the pharmaceutical manufacturing and supply chain security. Matters relating to the pharmaceutical manufacturing and supply chain security.

Follow WST
Became public
Oct 19, 2026, 6:19 PM EDT
Event / period date
Not stated
Collected
Nov 11, 2026, 10:49 AM EST

Why this is connected

Exact legal-name match: WEST PHARMACEUTICAL SERVICES INC (https://www.sec.gov/Archives/edgar/data/105770/).

Reported lobbying amounts

Income: $20,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/24136166-b989-4643-ba22-10cf53136792/","filing_uuid":"24136166-b989-4643-ba22-10cf53136792","filing_type":"3T","filing_type_display":"3rd Quarter - Termination","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/24136166-b989-4643-ba22-10cf53136792/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Anthony Campau","dt_posted":"2026-10-19T18:19:55-04:00","termination_date":"2026-07-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1001 Pennsylvania Avenue NW, Suite 1300S","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401106670,"url":"https://lda.gov/api/v1/registrants/401106670/","house_registrant_id":45635,"name":"CLARK HILL PUBLIC STRATEGIES LLC","description":null,"address_1":"1001 Pennsylvania Avenue NW, Suite 1300S","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY CAMPAU","contact_telephone":"+1 240-331-8804","dt_updated":"2026-07-17T13:00:21.626343-04:00"},"client":{"id":64539,"url":"https://lda.gov/api/v1/clients/64539/","client_id":64539,"name":"WEST PHARMACEUTICAL SERVICES, INC.","general_description":"Pharmaceuticals","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-24"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155507,"prefix":null,"prefix_display":null,"first_name":"L.","nickname":null,"middle_name":"J.","last_name":"CHAVIS","suffix":null,"suffix_display":null},"covered_position":"Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17).","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155507,"prefix":null,"prefix_display":null,"first_name":"L.","nickname":null,"middle_name":"J.","last_name":"CHAVIS","suffix":null,"suffix_display":null},"covered_position":"Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17).","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Matters relating to the pharmaceutical manufacturing and supply chain security.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147877,"prefix":null,"prefix_display":null,"first_name":"CONRAD","nickname":null,"middle_name":null,"last_name":"FURLICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144750,"prefix":null,"prefix_display":null,"first_name":"ANTHONY","nickname":null,"middle_name":null,"last_name":"CAMPAU","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff and Counselor, Office of Information and Regulatory Affairs (OIRA), U.S. Office of Management and Budget (OMB), Executive Office of the President (EOP); Transition Staff, OMB/OIRA; Regulatory Reform Team, Presidential Transition Team.","new":false},{"lobbyist":{"id":151842,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"ALEKSANYAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155507,"prefix":null,"prefix_display":null,"first_name":"L.","nickname":null,"middle_name":"J.","last_name":"CHAVIS","suffix":null,"suffix_display":null},"covered_position":"Rep. Jackson,Dep. Legisl. Dir.(2025),Legisl. Asst.(2023-25); Rep. Cherfilus-McCormick,Legal Fellow(2022-23); Sen. Special Comm. on Aging,Intern(2022); Sen. Sasse,Intern(2017-18); Rep. Pittenger,Research Asst.(2017); Rep. Farenthold,Intern(2016-17).","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in WST

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.